Aldeyra Therapeutics
ALDX
ALDX
77 hedge funds and large institutions have $103M invested in Aldeyra Therapeutics in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 18 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
7% more funds holding
Funds holding: 72 → 77 (+5)
2.18% more ownership
Funds ownership: 61.15% → 63.33% (+2.2%)
47% less call options, than puts
Call options by funds: $213K | Put options by funds: $405K
Holders
77
Holding in Top 10
2
Calls
$213K
Puts
$405K
Top Buyers
| 1 | +$3.71M | |
| 2 | +$1.54M | |
| 3 | +$460K | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$377K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$309K |
Top Sellers
| 1 | -$3.62M | |
| 2 | -$2.43M | |
| 3 | -$487K | |
| 4 |
Squarepoint
New York
|
-$325K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$264K |